PerkinElmer (NYSE:PKI) Third Quarter 2022 Results
Key Financial Results
Revenue: US$711.8m (down 17% from 3Q 2021).
Net income: US$69.5m (down 35% from 3Q 2021).
Profit margin: 9.8% (down from 13% in 3Q 2021). The decrease in margin was driven by lower revenue.
EPS: US$0.55 (down from US$0.94 in 3Q 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
PerkinElmer EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 37%.
Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 5.9% growth forecast for the Life Sciences industry in the US.
The company's shares are up 10% from a week ago.
Be aware that PerkinElmer is showing 2 warning signs in our investment analysis and 1 of those is a bit concerning...
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here